Anika Therapeutics, Inc. — Director's Dealing 2012

Mar 16, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANIKA THERAPEUTICS INC (ANIK)
CIK: 0000898437
Period of Report: 2012-03-14

Reporting Person: SHERWOOD CHARLES H (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-03-14	Common Stock	M	12500	$1.05	Acquired	301280	Direct
2012-03-14	Common Stock	M	37500	$1.16	Acquired	338780	Direct
2012-03-14	Common Stock	F	20000	$12.15	Disposed	318780	Direct

Footnotes

F1: Exercise of stock options granted on March 21, 2002 and that vested in four equal installments annually beginning March 21, 2003.

F2: Exercise of stock options granted on April 11, 2002 and that vested in four equal installments annually beginning April 11, 2003.

F3: Sale of non-qualified stock options exercised March 14, 2012 at market price in order to fund exercise price and tax liability.